Melis Maria Rosaria, Succu Salvatora, Mascia Maria Stefania, Sanna Fabrizio, Melis Tiziana, Castelli Maria Paola, Argiolas Antonio
Bernard B Brodie Department of Neuroscience and Centre of Excellence for The Neurobiology of Addictions, University of Cagliari, 09042 Monserrato, Italy.
Neuropharmacology. 2006 Feb;50(2):219-28. doi: 10.1016/j.neuropharm.2005.09.009. Epub 2005 Nov 9.
The cannabinoid CB1 receptor antagonist SR141716A (0.5, 1 and 2 microg) induces penile erection when injected into the paraventricular nucleus of male rats. The pro-erectile effect of SR 141716A occurs concomitantly with an increase in the concentration of NO2- and NO3- in the paraventricular dialysate obtained by means of intracerebral microdialysis. Both penile erection and NO2- increase induced by SR 141716A were reduced by the prior injection into the PVN of the cannabinoid CB1 agonists WIN 55,212-2 (5 microg) or HU 210 (5 microg), given into the paraventricular nucleus at doses unable to induce penile erection or to modify NO2- concentration. SR 141716A responses were also reduced by nitro-L-arginine methylester (20 microg), a non-selective NO synthase inhibitor, S-methyl-L-thiocitrulline (20 microg), a selective neuronal NO synthase inhibitor, the excitatory amino acid NMDA receptor antagonist dizocilpine ((+)MK 801) (1 microg), or the GABAA receptor agonist muscimol (0.2 microg) injected into the PVN 15 min before SR 141716A. In contrast, the inducible NO synthase inhibitor L-N(6)-(1-iminoethyl)lysine (20 microg), the GABAB receptor agonist baclofen (0.2 microg), the mixed dopamine receptor antagonist cis-flupenthixol (10 microg), and the oxytocin receptor antagonist d(CH2)5Tyr(Me)-Orn8 -vasotocin (1 microg), were ineffective. Despite its inability to reduce penile erection and NO2- increase induced by SR 141716A when injected into the PVN, d(CH2)5Tyr(Me)-Orn8 -vasotocin (1 microg) reduced almost completely penile erection without reducing paraventricular NO2- increase when injected into the lateral ventricles 15 min before SR 141716A. The present results show that SR 141716 induces penile erection by a mechanism (possibly activation of excitatory amino acid neurotransmission), which causes the activation of neuronal NO synthase in paraventricular oxytocinergic neurons mediating penile erection.
大麻素CB1受体拮抗剂SR141716A(0.5、1和2微克)注入雄性大鼠室旁核时可诱导阴茎勃起。SR141716A的促勃起作用与通过脑内微透析获得的室旁核透析液中NO2-和NO3-浓度的增加同时出现。SR141716A诱导的阴茎勃起和NO2-增加在预先向室旁核注射大麻素CB1激动剂WIN 55,212-2(5微克)或HU 210(5微克)后均减弱,WIN 55,212-2和HU 210的注射剂量无法诱导阴茎勃起或改变NO2-浓度。硝基-L-精氨酸甲酯(20微克,一种非选择性一氧化氮合酶抑制剂)、S-甲基-L-硫代瓜氨酸(20微克,一种选择性神经元一氧化氮合酶抑制剂)、兴奋性氨基酸NMDA受体拮抗剂地佐环平((+)MK 801)(1微克)或GABAA受体激动剂蝇蕈醇(0.2微克)在SR141716A注射前15分钟注入室旁核,也会减弱SR141716A的反应。相比之下,诱导型一氧化氮合酶抑制剂L-N(6)-(1-亚氨基乙基)赖氨酸(20微克)、GABAB受体激动剂巴氯芬(0.2微克)、混合多巴胺受体拮抗剂顺式氟哌噻吨(10微克)以及催产素受体拮抗剂d(CH2)5Tyr(Me)-Orn8-血管加压素(1微克)均无效。尽管d(CH2)5Tyr(Me)-Orn8-血管加压素(1微克)注入室旁核时无法减弱SR141716A诱导的阴茎勃起和NO2-增加,但在SR141716A注射前15分钟注入侧脑室时,它几乎完全抑制了阴茎勃起,而未减弱室旁核NO2-的增加。目前的结果表明,SR141716通过一种机制(可能是激活兴奋性氨基酸神经传递)诱导阴茎勃起,该机制导致介导阴茎勃起的室旁核催产素能神经元中的神经元一氧化氮合酶被激活。